Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
Rashedi S, Greason CM, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Kreuziger LMB, Lang IM, Goldhaber SZ, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B.
Rashedi S, et al. Among authors: braunwald e.
Semin Thromb Hemost. 2024 Mar 1. doi: 10.1055/s-0044-1781451. Online ahead of print.
Semin Thromb Hemost. 2024.
PMID: 38428841